By repressing CHAC1, the FOXG1:TLE1 complex aids in the survival and proliferation of GBM cells, making CHAC1 a promising target for therapeutic strategies aimed at combating gliomagenesis (Dali et al., 2018). The gene discussed is CHAC1; the disease is glioblastoma.